Brief: OncoCyte Corp Says On July 8, Got Notice From Nasdaq That Co Regained Compliance With Listing Rules
12/07/2024 21:34
July 12 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE CORP: ON JULY 8, GOT NOTICE FROM NASDAQ THAT CO
REGAINED COMPLIANCE WITH NASDAQ LISTING RULES 5605(B)(1) AND
5605(C)(2)
Source text for Eikon: ID:n0001493152-24-027086
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission